CORC  > 中国医学科学院 北京协和医学院
Safety of a quadrivalent human papillomavirus vaccine in a Phase 3, randomized, double-blind, placebo-controlled clinical trial among Chinese women during 90 months of follow-up
Chen, Wen; Zhao, Yun; Xie, Xing; Liu, Jihong; Li, Jingran; Zhao, Chao; Wang, Shaoming; Liao, Xueyan; Shou, Qiong; Zheng, Minghuan
2019
卷号37期号:6页码:889-897
关键词Safety Quadrivalent human papillomavirus vaccine Randomised controlled trial
ISSN号0264-410X
DOI10.1016/j.vaccine.2018.12.030
URL标识查看原文
收录类别SCIE ; PUBMED
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/6344674
专题中国医学科学院 北京协和医学院
推荐引用方式
GB/T 7714
Chen, Wen,Zhao, Yun,Xie, Xing,et al. Safety of a quadrivalent human papillomavirus vaccine in a Phase 3, randomized, double-blind, placebo-controlled clinical trial among Chinese women during 90 months of follow-up[J],2019,37(6):889-897.
APA Chen, Wen.,Zhao, Yun.,Xie, Xing.,Liu, Jihong.,Li, Jingran.,...&Qiao, Youlin.(2019).Safety of a quadrivalent human papillomavirus vaccine in a Phase 3, randomized, double-blind, placebo-controlled clinical trial among Chinese women during 90 months of follow-up.,37(6),889-897.
MLA Chen, Wen,et al."Safety of a quadrivalent human papillomavirus vaccine in a Phase 3, randomized, double-blind, placebo-controlled clinical trial among Chinese women during 90 months of follow-up".37.6(2019):889-897.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace